Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
May 17, 2022
Patent Application Number
17077877
Date Filed
October 22, 2020
Patent Citations
Patent Primary Examiner
The present invention generally relates to antibodies, antigen-binding fragments thereof, polypeptides, and immunoconjugates that bind to CD123 antigen (the α chain of the interleukine 3 receptor, or IL-3Rα). The present invention also relates to methods of using such CD123-binding molecules for diagnosing and treating diseases, such as B-cell malignancies.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
